Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

NULL
   
  • Closing Price Chg:
    -2.00p
  • 52 Week High: NULL
  • 52 Week Low: 177.00p
  • Currency: UK Pounds
  • Shares Issued: 219.24m
  • Volume: 0
  • RiskGrade: 156
  • Beta: 0.03

Director dealings: Advanced Medical Solutions director snaps up shares

By Iain Gilbert

Date: Friday 11 Oct 2024

LONDON (ShareCast) - (Sharecast News) - Advanced Medical Solutions revealed on Friday that non-executive director Grahame Cook had acquired 48,864 ordinary shares in the AIM-listed tissue-healing technologies business.

Cook, who was appointed to the board of AMS in February 2021, purchased the shares on Thursday at an average price of 205.25p each, for a total value of £100,239.36.

As of 1630 BST, Advanced Medical Solutions shares were flat at 202.50p.







Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Various Eateries (VARE)
Director name: Osmond,Hugh
Amount purchased: 2,000,000 @ 15.00p
Value: £300,000.01

Advanced Medical Solutions Group (AMS)
Director name: Cook,Grahame
Amount purchased: 48,864 @ 205.25p
Value: £100,293.36

Lindsell Train Inv Trust (LTI)
Director name: Lindsell,Michael
Amount purchased: 67 @ 73,323.64p
Value: £49,126.84

Naked Wines (WINE)
Director name: Pailing,Jack
Amount purchased: 70,169 @ 58.46p
Value: £41,020.38

Insig Ai (INSG)
Director name: Bernstein,Richard
Amount purchased: 350,000 @ 11.50p
Value: £40,250.00

Unicorn Mineral Resources Eur0.01 (cdi) (UMR)
Director name: Doherty,Patrick
Amount purchased: 300,000 @ 8.89p
Value: £26,670.00

Naked Wines (WINE)
Director name: Pailing,Jack
Amount purchased: 29,831 @ 59.14p
Value: £17,641.49

Unicorn Mineral Resources Eur0.01 (cdi) (UMR)
Director name: Doherty,Patrick
Amount purchased: 200,000 @ 8.56p
Value: £17,120.00

Intercede Group (IGP)
Director name: Patel,Nitil
Amount purchased: 1,504 @ 162.20p
Value: £2,439.49

Spirax Group (SPX)
Director name: Patel,Nimesh
Amount purchased: 24 @ 7,341.67p
Value: £1,762.00



Top Director Sells

Renalytix (reg S) (RENX)
Director name: Mills,Christopher H B
Amount sold: 83,696 @ 8.00p
Value: £6,695.68

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change -2.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 177.00p
Volume 0
Shares Issued 219.24m
Beta 0.03
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.95% below the market average92.95% below the market average92.95% below the market average92.95% below the market average92.95% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
Price Trend
47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average47.48% below the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average
Income
84.7% below the market average84.7% below the market average84.7% below the market average84.7% below the market average84.7% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
16.85% below the market average16.85% below the market average16.85% below the market average16.85% below the market average16.85% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Jun-25 26-Sep-24
Paid 17-Jul-25 25-Oct-24
Amount 1.83p 0.77p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson

Top of Page